Skip to main content
Signal8

Amin Naseem

SEC insider (Form 3/4/5 filer). CIK 0001646754. Director at AVADEL PHARMACEUTICALS PLC (AVDL). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in DUBLIN 2, L2.

Companies Amin Naseem has filed insider reports for

  • AVADEL PHARMACEUTICALS PLC (AVDL): Director
Amin Naseem profile photo

Amin Naseem

CIK: 0001646754

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AVADEL PHARMACEUTICALS PLC logo
AVDL

AVADEL PHARMACEUTICALS PLC

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • AVADEL PHARMACEUTICALS PLC logo
    AVDL

    AVADEL PHARMACEUTICALS PLC

    Feb 12, 2026
    Disposition
    Direct
    22K shares at avg. $21.00$462K
  • AVADEL PHARMACEUTICALS PLC logo
    AVDL

    AVADEL PHARMACEUTICALS PLC

    Jul 29, 2025
    Award
    Direct
    11K shares-

1-2 of 2